IPP Bureau
Ashland signs definitive agreement to sell nutraceuticals business to Turnspire Capital Partners
By IPP Bureau - May 09, 2024
Ashland's nutraceuticals business supplies a broad portfolio of active ingredients and formulation aids to nutritional product companies
Aarti Drugs posts Q4 FY24 consolidated PAT at Rs. 47.37 Cr
By IPP Bureau - May 09, 2024
The company has posted net profit of Rs.171.42 crores for the Financial Year ended March 31, 2024
WACKER expands production capacity for biopharmaceuticals in San Diego
By IPP Bureau - May 08, 2024
Wacker Biotech US, a wholly owned subsidiary of Wacker Chemie AG, specializes in the microbial production of pDNA
Sumitomo Corporation makes full-scale entry into private clinic business in fast-growing southeast Asia
By IPP Bureau - May 08, 2024
Investing in Malaysia's largest clinic operator to expand the healthcare business
AstraZeneca’s Calquence combination regimen demonstrated positive results in 1st-line mantle cell lymphoma in ECHO Phase III trial
By IPP Bureau - May 08, 2024
First BTK inhibitor to show favourable trend in overall survival vs. standard-of-care chemoimmunotherapy in this setting
USFDA accepts Bristol Myers Squibb’s application for subcutaneous nivolumab
By IPP Bureau - May 08, 2024
Subcutaneous nivolumab has potential to be the first and only subcutaneously administered PD-1 inhibitor
AstraZeneca completes equity investment agreement with Cellectis
By IPP Bureau - May 08, 2024
Cellectis is also eligible to receive an investigational new drug (IND) option fee and development
Aptar Closures introduces new e-Commerce disc top closure for beauty, personal and home care applications
By IPP Bureau - May 08, 2024
Aptar Closures’ E-Disc Top securely protects against in-transit leakage while eliminating the need for liners and extra shipping preparation fees
Caplin Point gets Colombia approval for Softgel Capsules
By IPP Bureau - May 07, 2024
The Unit currently caters to emerging markets of Latin America and Africa with a variety of dosage forms
Alembic Pharmaceuticals receives EIR from USFDA for oncology formulation facility
By IPP Bureau - May 07, 2024
With this, for all our USFDA facilities, EIRs are in place
Lupin receives USFDA approval for travoprost ophthalmic solution
By IPP Bureau - May 07, 2024
Travoprost Ophthalmic Solution USP, 0.004%, is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.
Suven Life Sciences posts Q4 FY24 consolidated loss at Rs. 26.54 Cr
By IPP Bureau - May 07, 2024
The company has posted net loss of Rs. 105.07 crores for the Financial Year ended March 31, 2024
Dr. Reddy's Laboratories launches Doxycycline Capsules, 40 mg in US
By IPP Bureau - May 06, 2024
ORACEA is a trademark of Galderma Holdings, S.A.
Briefs: Eugia Pharma Specialities and IOL Chemicals and Pharmaceuticals
By IPP Bureau - May 06, 2024
Eugia Pharma Specialities receives 7 observations from USFDA for Unit II
Amrutanjan Health Care to set up Rs. 132 crore plant for sanitary napkins
By IPP Bureau - May 06, 2024
The project funding will be done through a mix of internal accruals and debts.
